Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-062649

Director bought 3,050 shares at an average $2.22 ($6,778)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2022-12-01 Purchase +105 $2.33 $245 202,010 D
Krogulski Kenneth Director 2022-12-02 Purchase +105 $2.31 $243 202,115 D
Krogulski Kenneth Director 2022-12-05 Purchase +105 $2.19 $230 202,220 D
Krogulski Kenneth Director 2022-12-06 Purchase +105 $2.19 $230 202,325 D
Krogulski Kenneth Director 2022-12-07 Purchase +105 $2.18 $229 202,430 D
Krogulski Kenneth Director 2022-12-08 Purchase +105 $2.19 $230 202,535 D
Krogulski Kenneth Director 2022-12-09 Purchase +105 $2.15 $226 202,640 D
Krogulski Kenneth Director 2022-12-12 Purchase +105 $2.14 $225 202,745 D
Krogulski Kenneth Director 2022-12-13 Purchase +320 $2.18 $698 203,065 D
Krogulski Kenneth Director 2022-12-14 Purchase +320 $2.21 $707 203,385 D
Krogulski Kenneth Director 2022-12-15 Purchase +144 $2.24 $323 203,529 D
Krogulski Kenneth Director 2022-12-16 Purchase +246 $2.22 $546 203,775 D
Krogulski Kenneth Director 2022-12-19 Purchase +450 $2.21 $995 204,225 D
Krogulski Kenneth Director 2022-12-20 Purchase +370 $2.31 $855 204,595 D
Krogulski Kenneth Director 2022-12-21 Purchase +360 $2.22 $799 204,955 D
Open-market purchases · 3,050 sh · avg $2.22 · $6,778
Loading xslF345X03/doc4.xml…